According to the World Health Organization (WHO), a total of 325 million people are affected by viral hepatitis worldwide, causing nearly 1.1 million deaths per year.
The prevalence of viral hepatitis in the Moroccan population is estimated at 2.5% for hepatitis B virus and 1.2% for hepatitis C virus, WHO said, adding that Studies limited to certain vulnerable groups have reported a higher prevalence, particularly among dialysis patients, people who inject drugs and people living with HIV.
In order to provide reliable epidemiological data capable of guiding interventions against this infection, and in accordance with the national strategic plan for the fight against viral hepatitis, the Ministry of Health has carried out, in collaboration with WHO and UNICEF, the first national survey on the seroprevalence of viral hepatitis, the results of which will be announced before the end of 2021. More than 12,000 people aged five and over took part in this survey.
In addition, the local manufacture and marketing of new antiviral molecules for the treatment of hepatitis C in Morocco reflects the firm commitment of the Ministry of Health to ensure the availability of the safest and most effective treatments at an affordable price. , the health ministry said in a statement.
In line with the Sustainable Development Goals, the Ministry of Health aims to eliminate the hepatitis C virus from the most vulnerable groups by 2023 and eliminate it from the general population by 2030.